New hope for kids with rare swelling disorder: daily pill may stop attacks

NCT ID NCT05453968

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a daily medication called berotralstat in 29 children aged 2 to under 12 who have hereditary angioedema (HAE), a condition that causes sudden, painful swelling attacks. The goal is to find the right dose based on weight and to check if it is safe and effective at preventing these attacks. Participants take the pill daily and are monitored for side effects and attack frequency.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY ANGIOEDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hereditary angioedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Investigative Site #1

    Vienna, Ontario, Austria

  • Investigative Site #1

    Ottawa, Ontario, Canada

  • Investigative Site #1

    Paris, France

  • Investigative Site #1

    Berlin, Germany

  • Investigative Site #1

    Tel Aviv, Israel

  • Investigative Site #1

    Padova, Italy

  • Investigative Site #1

    Krakow, Poland

  • Investigative Site #1

    Sângeorgiu de Mureş, Romania

  • Investigative Site #1

    Madrid, Spain

  • Investigative Site #1

    Bristol, United Kingdom

  • Investigative Site #2

    Marseille, France

  • Investigative Site #2

    Frankfurt, Germany

  • Investigative Site #2

    Haifa, Israel

  • Investigative Site #2

    Málaga, Spain

  • Investigative Site #3

    Grenoble, France